Source: International Congress 2019 – Cardiovascular comorbidities in COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
F. Yangui (Tunis, Tunisia), A. Touil (Tunis, Tunisia), S. Antit (Tunis, Tunisia), L. Zakhama (Tunis, Tunisia), S. Ben Youssef (Tunis, Tunisia), M. Charfi (Tunis, Tunisia). Prevalence of lung function abnormalities in smokers with ischemic heart disease. 2667

Member's Comments

No comment yet.

Related content which might interest you: Prevalence and characteristics of congestive heart failure in elderly patients with chronic lung disease Source: Annual Congress 2009 - Pulmonary embolism and cardiovascular diseases Year: 2009 Alterations in cardiovascular function in COPD and heart failure patients with sarcopenia Source: Virtual Congress 2020 – Exploring exercise responses in respiratory diseases Year: 2020 Clinical and functional characteristics of patients with acute severe COPD with or without ischemic heart disease Source: Eur Respir J 2006; 28: Suppl. 50, 162s Year: 2006 Relationships between exacerbation symptoms, recovery and ischaemic heart disease in COPD Source: Annual Congress 2010 - COPD: cardiovascular comorbidities Year: 2010 Obscure chronic obstructive pulmonary disease in tobacco smokers having ischemic heart disease Source: Annual Congress 2013 –COPD and tobacco management Year: 2013 Relationship between lung function impairment and incidence or recurrence of cardiovascular disease in a middle-aged cohort Source: Annual Congress 2007 - Longitudinal and cross sectional risk factors for COPD Year: 2007 Chronic obstructive pulmonary disease does not increase the risk of ischaemic heart disease Source: Annual Congress 2009 - Prognosis and comorbidities in COPD Year: 2009 Differences of functional capacity between patients with left heart failure and rightheart failure associated with chronic pulmonary diseases Source: Virtual Congress 2020 – Pulmonary embolism and beyond Year: 2020 Ischemic heart disease in patients with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 706s Year: 2007 Prevalence and impact of small airways dysfunction in patients with ischemic heart disease Source: International Congress 2014 – Pathophysiological mechanisms at different scales Year: 2014 COPD prevalence in chronic heart failure Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity Year: 2011 Underlying ischaemic heart disease assessed by cardiac infarction injury score (CIIS) is under-recognised in our patients hospitalised for COPD exacerbation Source: Annual Congress 2010 - COPD: treatment and monitoring Year: 2010 Effects of cardiovascular agents on respiratory function in COPD patients with concomitant coronary heart disease Source: Eur Respir J 2002; 20: Suppl. 38, 247s Year: 2002 Systemic manifestations and comorbidities of COPD Source: Eur Respir J 2009; 33: 1165-1185 Year: 2009 Predictive factors of lung function in patients with COPD and heart failure Source: Virtual Congress 2020 – Diagnosis and management of COPD Year: 2020 COPD phenotypes not linked to increased risk of coronary heart disease Source: International Congress 2019 – Comorbidities galore in respiratory patients Year: 2019 Frequency of adverse consequences after spirography in patients with chronic obstructive pulmonary disease and concomitant ischemic heart disease Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases Year: 2016 Patterns of lung function abnormalities in smokers as possible manifestation of "early" COPD phenotypes Source: Annual Congress 2012 - New issues in pulmonary function Year: 2012 Hypoxia as a risk factor for arrhythmias in patients with chronic obstructive pulmonary disease and heart failure Source: International Congress 2019 – More and more COPD Year: 2019 OSA as a cause of cardiovascular disease, including heart failure Source: ERS Conference Year: 2015